Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Cytokines

Recombinant Human FGF14 Protein, N-His

Catalog #:   YHK09301 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q92915
Protein length: Met1-Thr252
Overview

Catalog No.

YHK09301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Thr252

Predicted molecular weight

29.65 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q92915

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Fibroblast growth factor 14, FGF-14, Fibroblast growth factor homologous factor 4, FHF-4, FGF14, FHF4

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human FGF14 protein
References

Increased expression of FGF14 and SCN2A/SCN11A is associated with better survival of HCC patients., PMID:40329566

Loss of intracellular FGF14 (iFGF14) increases excitability of mature hippocampal pyramidal neurons., PMID:40323232

Deletion of Fgf14 confers resilience to basal and stress-induced depressive-like behavior and reduces anxiety in mice., PMID:40204701

Novel In-Frame FGF14 Deletion Causes Spinocerebellar Ataxia Type 27A: Clinical Response to Deep Brain Stimulation and 4-Aminopyridine., PMID:40156335

Production and purification of recombinant long protein isoforms of FGF11 subfamily., PMID:40154621

Identifcation of the FGF family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma., PMID:40086631

Late-onset vestibulocerebellar ataxia: clinical and genetic studies in a long follow-up series of 50 patients., PMID:40024931

Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders., PMID:39918711

Delayed Progression of Ataxia with a Static Cerebellar Lesion- Consider SCA27B., PMID:39821862

Developmental changes of skin quality from breast, back, and thigh of Pekin ducks from 1 to 6 weeks of age., PMID:39817987

Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6 complex in nucleus accumbens neurons., PMID:39747162

The First Case of Autosomal Recessive Cerebellar Ataxia with Prominent Paroxysmal Non-kinesigenic Dyskinesia Caused by a Truncating FGF14 Variant in a Turkish Patient., PMID:39704271

How to distinguish spinocerebellar ataxia 27B from late onset cerebellar ataxia: insights from a case-control study., PMID:39666053

Frequency of FGF14 intronic GAA repeat expansion in patients with multiple system atrophy and undiagnosed ataxia in the Japanese population., PMID:39604554

Molecular Signatures of Resilience to Alzheimer's Disease in Neocortical Layer 4 Neurons., PMID:39574639

Screening for SCA27B, CANVAS and other repeat expansion disorders in Greek patients with late-onset cerebellar ataxia suggests a need to update current diagnostic algorithms., PMID:39571249

In Vivo Expression of an SCA27A-linked FGF14 Mutation Results in Haploinsufficiency and Impaired Firing of Cerebellar Purkinje Neurons., PMID:39484407

Somatic instability of the FGF14-SCA27B GAA•TTC repeat reveals a marked expansion bias in the cerebellum., PMID:39378335

Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B)., PMID:39263992

Identification and characterisation of pathogenic and non-pathogenic FGF14 repeat expansions., PMID:39227614

The episodic ataxias., PMID:39174244

Genetic profiles of multiple system atrophy revealed by exome sequencing, long-read sequencing and spinocerebellar ataxia repeat expansion analysis., PMID:39152783

Introducing effective genes in lymph node metastasis of breast cancer patients using SHAP values based on the mRNA expression data., PMID:39150915

Crosstalk among WEE1 Kinase, AKT, and GSK3 in Nav1.2 Channelosome Regulation., PMID:39125637

Low prevalence of SCA27B in adult-onset cerebellar ataxia cohort of Jewish ancestry., PMID:39003951

Spinocerebellar ataxia type 27B (SCA27B) in India: insights from a large cohort study suggest ancient origin., PMID:38976084

A common flanking variant is associated with enhanced stability of the FGF14-SCA27B repeat locus., PMID:38937606

Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia-experience from an Italian cohort., PMID:38886208

Characteristics of tandem repeat inheritance and sympathetic nerve involvement in GAA-FGF14 ataxia., PMID:38866925

Complete nanopore repeat sequencing of SCA27B (GAA-FGF14 ataxia) in Japanese., PMID:38816190

Spinocerebellar ataxia 27B (SCA27B), a frequent late-onset cerebellar ataxia., PMID:38609751

GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort., PMID:38507876

RFC1 and FGF14 Repeat Expansions in Serbian Patients with Cerebellar Ataxia., PMID:38487929

FGF14 GAA repeat expansion and ZFHX3 GGC repeat expansion in clinically diagnosed multiple system atrophy patients., PMID:38472396

RFC1 repeat expansions in downbeat nystagmus syndromes: frequency and phenotypic profile., PMID:38381176

The FGF14 gene is a milestone in ataxia genetics., PMID:38301484

TNFR1 signaling converging on FGF14 controls neuronal hyperactivity and sickness behavior in experimental cerebral malaria., PMID:38115011

Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan., PMID:37916889

Genomic selection pressure discovery using site-frequency spectrum and reduced local variability statistics in Pakistani Dera-Din-Panah goat., PMID:37750990

Reply to: "Non-GAA Repeat Expansions in FGF-14 Are Likely Not Pathogenic"., PMID:37565403

Autosomal dominant cerebellar ataxias: new genes and progress towards treatments., PMID:37479376

Natural History and Phenotypic Spectrum of GAA-FGF14 Sporadic Late-Onset Cerebellar Ataxia (SCA27B)., PMID:37470282

Sex-Specific Genetic Determinants of Asthma-COPD Phenotype and COPD in Middle-Aged and Older Canadian Adults: An Analysis of CLSA Data., PMID:37466093

Pearls & Oy-sters: ATX-FGF14 Mimicking Autoimmune Pathology., PMID:37460234

FGF homologous factors are secreted from cells to induce FGFR-mediated anti-apoptotic response., PMID:37342898

Shaking Up Ataxia: FGF14 and RFC1 Repeat Expansions in Affected and Unaffected Members of a Chilean Family., PMID:37246629

Deep intronic FGF14 GAA-repeat expansion in late-onset cerebellar ataxia: Last but not least., PMID:36906458

Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells., PMID:36750863

Genome-wide Association Study of Methotrexate-Induced Liver Injury in Rheumatoid Arthritis Patients., PMID:36708065

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human FGF14 Protein, N-His [YHK09301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only